Literature DB >> 26222258

How does the ketogenic diet induce anti-seizure effects?

Jong M Rho1.   

Abstract

The high-fat ketogenic diet (KD) is a remarkably effective treatment for medically intractable epilepsy and has been part of the clinical armamentarium for nearly a century. However, the mechanisms underlying the KD's actions have remained elusive. Over the past decade, there has been phenomenal international growth of clinical centers offering metabolism-based therapies for epilepsy, and rapidly expanding research into the cellular and biochemical effects induced by the KD. At present, there are many hypotheses regarding KD action, and while each is uniquely compelling, it is becoming more apparent that the KD likely works through multiple mechanisms that target fundamental biochemical pathways linked to cellular substrates (e.g., ion channels) and mediators responsible for neuronal hyperexcitability. This is not altogether surprising given the complexity of the epileptic brain, and the many different pathophysiologic mechanisms that underlie seizure genesis and epileptogenicity. The scientific literature involving the KD strongly supports the notion that epilepsy may indeed in part represent a "metabolic disease", and that this concept could serve as a novel framework for the development of more effective anti-seizure drugs.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Epilepsy; Ketogenic diet; Mechanism; Metabolism; Mitochondria; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26222258     DOI: 10.1016/j.neulet.2015.07.034

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  54 in total

Review 1.  New insights into the mechanisms of the ketogenic diet.

Authors:  Detlev Boison
Journal:  Curr Opin Neurol       Date:  2017-04       Impact factor: 5.710

Review 2.  Intractable Generalized Epilepsy: Therapeutic Approaches.

Authors:  Sean T Hwang; Scott J Stevens; Aradia X Fu; Simona V Proteasa
Journal:  Curr Neurol Neurosci Rep       Date:  2019-02-26       Impact factor: 5.081

Review 3.  Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies.

Authors:  Qian-Yun Cai; Zhong-Jie Zhou; Rong Luo; Jing Gan; Shi-Ping Li; De-Zhi Mu; Chao-Min Wan
Journal:  World J Pediatr       Date:  2017-07-12       Impact factor: 2.764

4.  Taming the rAMPAnt Fire with Fat.

Authors:  Libor Velíšek
Journal:  Epilepsy Curr       Date:  2017 Jan-Feb       Impact factor: 7.500

5.  BAD knockout provides metabolic seizure resistance in a genetic model of epilepsy with sudden unexplained death in epilepsy.

Authors:  Jeannine Foley; Veronica Burnham; Meghan Tedoldi; Nika N Danial; Gary Yellen
Journal:  Epilepsia       Date:  2017-11-23       Impact factor: 5.864

6.  SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures.

Authors:  Samantha Palmer; Meghan C Towne; Phillip L Pearl; Renee C Pelletier; Casie A Genetti; Jiahai Shi; Alan H Beggs; Pankaj B Agrawal; Catherine A Brownstein
Journal:  Pediatr Neurol       Date:  2016-07-28       Impact factor: 3.372

Review 7.  Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.

Authors:  Martin Holtkamp
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

Review 8.  β-Hydroxybutyrate: A Signaling Metabolite.

Authors:  John C Newman; Eric Verdin
Journal:  Annu Rev Nutr       Date:  2017-08-21       Impact factor: 11.848

9.  Glycolytic inhibitor 2-deoxyglucose prevents cortical hyperexcitability after traumatic brain injury.

Authors:  Jenny B Koenig; David Cantu; Cho Low; Mary Sommer; Farzad Noubary; Danielle Croker; Michael Whalen; Dong Kong; Chris G Dulla
Journal:  JCI Insight       Date:  2019-04-30

10.  Efficacy of a ketogenic diet with concomitant intranasal perillyl alcohol as a novel strategy for the therapy of recurrent glioblastoma.

Authors:  Juliana Guimarães Santos; Wanise Maria Souza Da Cruz; Axel H Schönthal; Marcela D'alincourt Salazar; Cristina Asvolinsque Pantaleão Fontes; Thereza Quirico-Santos; Clovis Orlando Da Fonseca
Journal:  Oncol Lett       Date:  2017-11-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.